Overview

To Evaluate the Pharmacokinetics and Safety of Oral Administration of BR9001 Compared With BR900A in Healthy Subjects

Status:
Completed

Trial end date:
2019-05-17

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the pharmacokinetics and safety of oral administration of BR9001 compared with BR900A in healthy subjects

Phase:

Phase 1

Details

Lead Sponsor:

Boryung Pharmaceutical Co., Ltd